Axonal transport is the directed movement of proteins, vesicles, RNAs, signaling endosomes, and organelles along microtubules between the neuronal soma and distal processes[1][2]. Because neurons are highly polarized and often extremely long—even exceeding one meter in human corticospinal neurons—even partial transport failure can destabilize synapses and axons, leading to progressive neurodegeneration[3].
The axonal transport system is essential for maintaining neuronal health, synaptic function, and axonal integrity. It operates bidirectionally: anterograde transport moves cargoes from the cell body toward synaptic terminals, while retrograde transport returns aged organelles, signaling endosomes, and misfolded proteins back to the soma for degradation or recycling[4].
Kinesins are the primary motor proteins responsible for anterograde transport. The kinesin-1 family (KIF5A, KIF5B, KIF5C) is the most extensively studied in neurons and moves cargoes toward the plus ends of microtubules (toward synaptic terminals)[5]. Kinesin-3 family members (KIF1A, KIF1B, KIF13B) mediate transport of synaptic vesicle precursors, BDNF signaling endosomes, and mitochondria[6].
Key kinesin adaptations in neurons include:
Other kinesin families involved in neuronal function include:
Dynein is the primary motor for retrograde transport, moving cargoes toward the minus ends of microtubules (toward the cell body)[7]. Dynein is a large complex (~1.5 MDa) composed of multiple subunits and requires accessory proteins (dynactin, BICD2) for processive movement[8].
Dynein-mediated retrograde transport is critical for:
Myosin-V and Myosin-VI operate primarily in dendritic and synaptic compartments, where they mediate short-range transport along actin filaments[9]. Myosin-V transports synaptic vesicle precursors from dendritic entry points to dendritic spines, while Myosin-VI functions in synaptic vesicle recycling and endocytosis[10].
Fast axonal transport moves membrane-bound organelles (synaptic vesicles, mitochondria, lysosomes, endosomes) at rates of 50–400 mm/day[11]. This transport is driven by kinesin and dynein motor proteins and requires ATP hydrolysis for movement.
Slow transport moves cytoskeletal proteins (tubulin, actin, neurofilaments), protein complexes, and ribonucleoproteins at rates of 0.1–3 mm/day[12]. This category is divided into:
Axonal transport delivers presynaptic proteins, synaptic vesicle proteins, and active zone components to synaptic terminals[13]. Disruption of synaptic vesicle transport leads to impaired neurotransmitter release and synaptic failure—early events in neurodegeneration.
Mitochondria are actively transported to regions with high energy demand, particularly synapses andNodes of Ranvier[14]. Mitochondrial transport is mediated by kinesin-1 (via Milton/Miro complex) and is regulated by calcium levels, ATP availability, and cellular signaling pathways[15].
Retrograde transport delivers misfolded proteins, protein aggregates, and damaged organelles to the soma for degradation via the autophagy-lysosome system[16]. Failure of this transport leads to accumulation of toxic aggregates in distal axons—a hallmark of many neurodegenerative diseases.
Trophic factor signaling endosomes (BDNF, NGF, GDNF) are transported retrogradely from synaptic terminals to the cell body, where they activate transcription factors and promote neuronal survival[17]. Disrupted trophic factor signaling is implicated in virtually all neurodegenerative disorders.
Microtubule post-translational modifications (acetylation, detyrosination, polyglutamylation) differentially affect motor protein binding and transport efficiency[18]. Axonal microtubules are typically more acetylated than dendritic microtubules, contributing to directional transport specificity.
Kinesin and dynein activities are regulated by:
Adaptor proteins link specific cargoes to motor proteins. Examples include:
Axonal transport defects are early events in AD pathogenesis. Key mechanisms include[19][20]:
PD involves specific vulnerabilities in dopaminergic neurons[21][22]:
Motor neurons are particularly vulnerable due to their extreme length[23]:
HD features early axonal transport defects[24][25]:
Several therapeutic approaches target axonal transport[26]:
Improving retrograde signaling endosome transport can enhance neurotrophic support:
| Protein | Motor Type | Cargo | AD Changes | PD Changes | ALS Changes | Therapeutic Target |
|---|---|---|---|---|---|---|
| Kinesin-1 | Anterograde | Organelles, vesicles | Impaired transport | Impaired transport | Impaired transport | - |
| Kinesin-3 | Anterograde | Synaptic vesicles | Reduced | Reduced | - | - |
| Dynein | Retrograde | Endosomes, organelles | Impaired | Impaired | Impaired | Dynein activators |
| dynactin | Dynein cofactor | Adaptor complex | Reduced | Reduced | Mutated | - |
| JIP1/3 | Kinesin adaptor | MAPs, cargo | Dysregulated | Dysregulated | - | - |
| LIS1 | Dynein regulator | Microtubule binding | Reduced | Reduced | - | - |
| HOOK3 | Cargo adaptor | Organelles | - | - | Mutated in ALS | - |
| Spastin | Microtubule severing | Severing enzyme | Impaired | - | Impaired | Spastin agonists |
Gunawardena S, et al. Axonal transport defects and neurodegeneration in Huntington's disease. Proc Natl Acad Sci USA. 2003. ↩︎
Hernandes MS, et al. Synaptopathies: synaptic dysfunction in neurological disorders. J Neurochem. 2016. ↩︎
Maday S, et al. Axonal transport in neuronal health and disease. Nat Rev Neurosci. 2014. ↩︎
Schroer JA, et al. Dynein function in neuronal transport. Trends Neurosci. 2012. ↩︎
Miki H, et al. Kinesin superfamily proteins in neuronal transport. Neuroscience. 2007. ↩︎
Huang J, et al. Kinesin-3 motors in neuronal polarity and trafficking. Neuron. 2019. ↩︎
Robinson JP, et al. Cytoplasmic dynein function and dysfunction. Annu Rev Neurosci. 2017. ↩︎
King SJ, et al. Dynactin: a coordinator of vesicle transport. Trends Cell Biol. 2018. ↩︎
Bridgman PC. Myosin-V and Myosin-VI in neuronal trafficking. Trends Neurosci. 2014. ↩︎
Yoshimura A, et al. Myosin-VI and synaptic vesicle recycling. Proc Natl Acad Sci USA. 2012. ↩︎
Brady ST, et al. Fast axonal transport in the nervous system. Trends Neurosci. 2009. ↩︎
Leterrier C, et al. Slow axonal transport: recent progress. Trends Neurosci. 2013. ↩︎
Giraud P, et al. Synaptic vesicle transport and synaptic function. Neuron. 2018. ↩︎
Sheng ZH. Mitochondrial trafficking in neurons. Trends Cell Biol. 2017. ↩︎
Devireddy S, et al. Miro proteins and mitochondrial transport. Trends Cell Biol. 2020. ↩︎
Koch JC, et al. Axonal transport of autophagosomes. J Cell Biol. 2016. ↩︎
Yamada M, et al. Retrograde signaling by neurotrophic factors. Trends Neurosci. 2017. ↩︎
Janke C, et al. Microtubule modifications and axonal transport. Trends Cell Biol. 2019. ↩︎
Mandelkow E, et al. Tau and axonal transport in Alzheimer's disease. Acta Neuropathol. 2019. ↩︎
Talbot K, et al. Axonal transport defects in Alzheimer's disease models. Neurobiol Dis. 2018. ↩︎
Chu Y, et al. Axonal transport in Parkinson's disease. Neurobiol Dis. 2019. ↩︎
Volpicelli-Daley L, et al. Alpha-synuclein and axonal transport. Mov Disord. 2020. ↩︎
Bilsland LG, et al. Axonal transport defects in ALS. Neurobiol Dis. 2017. ↩︎
Saudou F, et al. Huntingtin and axonal transport. Brain. 2016. ↩︎
Gao X, et al. Mutant huntingtin impairs axonal transport in HD. Neurobiol Dis. 2020. ↩︎
Morse LJ, et al. Therapeutic targeting of axonal transport in neurodegeneration. Trends Pharmacol Sci. 2020. ↩︎